Abstract:<h3 class="Heading">Background</h3><p class="Para">Apolipoprotein A-IV (ApoA-IV) exists in relatively high levels in the circulation systems of animals, but its roles are not fully elucidated. It is known that the <em class="EmphasisTypeItalic">Apoa4</em> gene resides in the cluster <em class="EmphasisTypeItalic">Apoa1</em>/<em class="EmphasisTypeItalic">Apoc3</em>/<em class="EmphasisTypeItalic">Apoa4</em>. Because of a short intergenic sequence between <em class="EmphasisTypeItalic">Apoc3</em> and <em class="EmphasisTypeItalic">Apoa4</em>, a previous ApoA-IV knockout mouse model by gene targeting had an accompanying deficiency in ApoC-III expression, which limited its application in investigating the precise roles of ApoA-IV. To solve this problem, we created a specific knockout of ApoA-IV in Sprague-Dawlay rats by TALEN approach.</p><h3 class="Heading">Methods</h3><p class="Para">Age-matched knockout rats and their wild-type littermate controls maintained on a standard rodent diet were studied and blood metabolic parameters were measured. Glucose, insulin, olive oil, and intralipid tolerance tests were performed to study the glucose and lipid metabolism of rats. Quantitative real-time PCR and RNA-seq analysis in liver and inguinal white adipose tissue (iWAT) of rats at three ages (18 weeks, 45 weeks and 90 weeks) were performed to identify the genes altered by ApoA-IV knockout.</p><h3 class="Heading">Results</h3><p class="Para">ApoA-IV knockout rats were apparently normal and fertile, but exhibited improved glucose clearance when challenged with glucose tolerance test. In addition, fasting-induced hepatic steatosis was more pronounced in ApoA-IV knockout rats. Further analysis identified that a set of hepatic genes involved in glycolysis, gluconeogenesis and <em class="EmphasisTypeItalic">de novo</em> lipogenesis were altered in the absence of ApoA-IV, which induced enhanced glycolysis, attenuated gluconeogenesis and elevated <em class="EmphasisTypeItalic">de novo</em> lipogenesis. And the RNA-seq results also confirmed that almost all the genes mentioned in the phenotyping section were highly consistent throughout the three studied ages.</p><h3 class="Heading">Conclusions</h3><p class="Para">ApoA-IV functions in an age-independent manner in the modulation of glucose and lipid metabolism of rats, and may serve as a potential linker between hepatic glucose and lipid metabolism.</p>

The Role of Apolipoprotein A-IV in Regulating Glucagon-Like Peptide-1 Secretion.

Is Apolipoprotein A-IV Rate Limiting in the Intestinal Transport and Absorption of Triglyceride?

Apolipoprotein A-IV involves in glucose and lipid metabolism of rat

Apolipoprotein A-1 Accelerated Liver Regeneration Through Regulating Autophagy Via AMPK-ULK1 Pathway.

Apolipoprotein A-IV-Deficient Mice in 129/SvJ Background Are Susceptible to Obesity and Glucose Intolerance

APOA5 deficiency causes hypertriglyceridemia by reducing amounts of lipoprotein lipase in capillaries

Apelin decreases lipolysis via G(q), G(i), and AMPK-Dependent Mechanisms

Exendin-4 Regulates Pancreatic ABCA1 Transcription Via CaMKK/CaMKIV Pathway

Attenuation of high‐fat diet‐induced weight gain by apolipoprotein A4

The physiology of glucagon-like peptide 1

Diet-Induced Obese Mice and Leptin-Deficient Lepob/ob Mice Exhibit Increased Circulating GIP Levels Produced by Different Mechanisms

Effects of apolipoprotein E on regulating insulin sensitivity via regulating insulin receptor signalosome in caveolae

Genetic disruption of the Gipr in Apoe-/- mice promotes atherosclerosis

Deficiency of apoA-IV in Female 129X1/SvJ Mice Leads to Diet-Induced Obesity, Insulin Resistance, and Decreased Energy Expenditure

Glucagon-like Peptide-1 Secretion Is Inhibited by Lysophosphatidic Acid

Effects and mechanisms of apolipoprotein A-V on the regulation of lipid accumulation in cardiomyocytes

Apelin Stimulates Glucose Utilization in Normal and Obese Insulin-Resistant Mice

ApoB48 as an Efficient Regulator of Intestinal Lipid Transport

Acute Inhibition of Adipose Triglyceride Lipase by NG497 Dysregulates Insulin and Glucagon Secretion from Human Islets

Glucagon-like peptide-1 and the entero-insular axis in obese hyperglycaemic (ob/ob) mice

The Area Postrema Lesions Alter the Inhibitory Effects of Peripherally Infused Pancreatic Polypeptide on Pancreatic Secretion